These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8130824)

  • 21. [Endometriosis and sterility: whom to treat and how?].
    Pierre F; Lansac J
    Rev Fr Gynecol Obstet; 1992 Jun; 87(6):316-8, 321-2. PubMed ID: 1631473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Polycystic ovary syndrome with infertility].
    Mourali M; Fkih C; Essoussi-Chikhaoui J; Ben Hadj HA; Binous N; Ben Zineb N
    Tunis Med; 2008 Nov; 86(11):963-72. PubMed ID: 19213486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
    Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
    Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Results of controlled ovarian stimulation for ART in poor responders according to the short protocol using different gonadotrophins combinations.
    Loutradis D; Elsheikh A; Kallianidis K; Drakakis P; Stefanidis K; Milingos S; Michalas S
    Arch Gynecol Obstet; 2004 Dec; 270(4):223-6. PubMed ID: 13680266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Assisted embryo hatching].
    Olivennes F; Vincent Y; Bergere M; Selva J; Frydman R
    Contracept Fertil Sex; 1993 Dec; 21(12):911-3. PubMed ID: 8130825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of low response to mild ovarian stimulation initiated on cycle day 5 for IVF.
    Verberg MF; Eijkemans MJ; Macklon NS; Heijnen EM; Fauser BC; Broekmans FJ
    Hum Reprod; 2007 Jul; 22(7):1919-24. PubMed ID: 17485438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [FSH and IVF management: the best and worst case scenarios].
    Aubriot FX; Chapron C
    Gynecol Obstet Fertil; 2008 Jun; 36(6):636-40. PubMed ID: 18538623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IVF/ICSI outcome and serum LH concentration on day 1 of ovarian stimulation with recombinant FSH under pituitary suppression.
    Bjercke S; Fedorcsak P; Abyholm T; Storeng R; Ertzeid G; Oldereid N; Omland A; Tanbo T
    Hum Reprod; 2005 Sep; 20(9):2441-7. PubMed ID: 15919773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A spontaneous luteinizing hormone surge is beneficial in women with unexplained infertility undergoing controlled ovarian hyperstimulation without in vitro fertilization.
    Costello MF; Hughes GJ; Garrett DK; Hanjani A; Steigrad SJ
    Int J Fertil Womens Med; 1998; 43(1):28-33. PubMed ID: 9532467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New advances in the treatment of infertility in women with ovarian failure.
    Morris RS; Sauer MV
    Curr Opin Obstet Gynecol; 1993 Jun; 5(3):368-77. PubMed ID: 8329653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allelic estrogen receptor 1 (ESR1) gene variants predict the outcome of ovarian stimulation in in vitro fertilization.
    Altmäe S; Haller K; Peters M; Hovatta O; Stavreus-Evers A; Karro H; Metspalu A; Salumets A
    Mol Hum Reprod; 2007 Aug; 13(8):521-6. PubMed ID: 17540666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of ovarian reserve by using the follicle-stimulating hormone isoform distribution pattern to predict the outcome of in vitro fertilization.
    Letterie GS; Lee JS; Padmanabhan V
    Fertil Steril; 2006 Nov; 86(5):1547-9. PubMed ID: 16999956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effectiveness of Humegon in drug-induced ovulation in women with infertility due to anovulation].
    Grcić R; Stavris V; Pestelek B
    Med Pregl; 1987; 40(5-6):197-200. PubMed ID: 3126382
    [No Abstract]   [Full Text] [Related]  

  • 34. Reduced pregnancy rates in AID women with unsuspected ovulatory failure.
    Dalrymple JC; Smith DH; Shuter B; Saunders DM
    Clin Reprod Fertil; 1983 Mar; 2(1):27-32. PubMed ID: 6640471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selection and pretreatment evaluation of patients treated with human menopausal gonadotropins.
    Mishell DR
    J Reprod Med; 1978 Sep; 21(3 Suppl):191-3. PubMed ID: 722706
    [No Abstract]   [Full Text] [Related]  

  • 36. The anovulatory patient. An orderly approach to evaluation and treatment.
    Blankstein J; Quigley MM
    Postgrad Med; 1988 Apr; 83(5):97-102. PubMed ID: 3128777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The ovarian factor in conjugal sterility].
    García Flores RF; Vázquez Méndez J
    Ginecol Obstet Mex; 1983 Jun; 51(314):157-61. PubMed ID: 6681298
    [No Abstract]   [Full Text] [Related]  

  • 38. [Complex therapy of functional sterility].
    Stĕrba R
    Zentralbl Gynakol; 1977; 99(14):872-6. PubMed ID: 906707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Five years' follow-up in two patients with borderline tumours of the ovary hyperstimulated by gonadotrophin therapy for in-vitro fertilization.
    Mantzavinos T; Kanakas N; Genatas C; Papadias K; Zourlas PA
    Hum Reprod; 1994 Nov; 9(11):2032-3. PubMed ID: 7868669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The ovarian hyperstimulation syndrome. Institutional experience].
    Serviere Zaragoza C; Camarero García A; Carranza Lira S; Kably Ambe A
    Ginecol Obstet Mex; 1994 Oct; 62():292-5. PubMed ID: 7995541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.